Table 1.

Patient characteristics.

No. patient visits (females)	494 (303)
No. RAND-36 measurements (PCS and MCS)	482
No. AddiQoL measurements (AddiQoL-8 and -30)	72
Age in decade years, median [IQR]	50-59 years [40-79]
Disease duration in years, median [IQR]	11 [4-24]
Positive for 21-hydroxylase autoantibodies, no. (%)	421 (85)
Presence of autoimmune comorbidity, no. (%)	293 (59)
APS-1, no. (%)	19 (4)
Hydrocortisone daily equivalent in mg, median [IQR]	30 [20-30]
Fludrocortisone daily dose in mg, median [IQR]	0.100 [0.100-0.100]